Eurofarma Laboratórios S.A. Share Price

Stocks

EUFA3

BREUFAACNOR4

Market Closed - Sao Paulo			5-day change	1st Jan Change
- ^BRL	-.--%		-.--%	-

14/08	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
15/05	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Latest news: Eurofarma Laboratórios S.A.

14/08	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
15/05	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
26/03	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
23/01	Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil	CI
10/12	Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors	CI
14/11	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
21/25/21	Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer	CI
21/25/21	SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform	CI
22/25/22	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
16/25/16	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
27/25/27	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
17/25/17	Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million.	CI
15/24/15	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

More news

Managers and Directors: Eurofarma Laboratórios S.A.

Manager	Title	Age	Since
Marco Billi CEO	Chief Executive Officer	-	23/11/2021
Alexandre Mendes Palhares IRC	Investor Relations Contact	40	23/11/2021

Director	Title	Age	Since
Maurízio Billi CHM	Chairman	-	23/11/2021
Cristina Presz Palmaka de Luca BRD	Director/Board Member	58	23/11/2021
Juliana Rozenbaum Munemori BRD	Director/Board Member	50	01/01/2019

More insiders

Latest insider transactions

Date	Insider	Type	Quantity	% Market Cap.
10/01/25	Controlling Shareholder Brazilian	Buy	16,44,236	0.1665%
04/12/24	Controlling Shareholder Brazilian	Sell	1,54,05,639	1.5600%
04/12/24	Controlling Shareholder Brazilian	Buy	1,54,05,639	1.5600%

Transaction History

Financials

	2024	2025
Net sales	1.1TCr 215.79Cr 191.81Cr 177.79Cr 161.76Cr 305.24Cr 20TCr 310.13Cr 2.14TCr 837.89Cr 11TCr 809.86Cr 792.61Cr 34TCr	1.25TCr 245.38Cr 218.12Cr 202.17Cr 183.94Cr 347.1Cr 23TCr 352.66Cr 2.43TCr 952.79Cr 12TCr 920.92Cr 901.31Cr 39TCr
Net income	12Cr 2.31Cr 2.05Cr 1.9Cr 1.73Cr 3.26Cr 218.9Cr 3.31Cr 23Cr 8.96Cr 114.23Cr 8.66Cr 8.47Cr 364.15Cr	57Cr 11Cr 9.99Cr 9.26Cr 8.42Cr 16Cr 1.07TCr 16Cr 111.3Cr 44Cr 556.59Cr 42Cr 41Cr 1.77TCr
Net Debt	-	-

Projected Income Statement - Annual - Eurofarma Laboratórios S.A.

* Estimated data More financial data

Company Profile

Employees

13,000

Sector

More about the company